NDC properties for "Phenazopyridine hydrochloride 200 MG / SMX 800 MG / TMP 160 MG Oral Tablet" (RxCUI 1094352)
About this data
The tables show NDC propoerties for Phenazopyridine hydrochloride 200 MG / SMX 800 MG / TMP 160 MG Oral Tablet with the RxCUI 1094352
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Phenazopyridine hydrochloride 200 MG / SMX 800 MG / TMP 160 MG Oral Tablet (RxCUI 1094352)
| RxCUI | 1094352 |
|---|---|
| SNOMEDCT | 410933000 |
| Prescribable Synonym | phenazopyridine HCl 200 MG / sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet |
| RXNAV_STR | phenazopyridine hydrochloride 200 MG / sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet |
| RxNorm Name | phenazopyridine hydrochloride 200 MG / sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet |
| RxNorm Synonym | Phenazopyridine hydrochloride 200 MG / SMX 800 MG / TMP 160 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 1094352) |
NDC Properties
no results for this query in NIH